Form 8-K

8-K — Drugs Made In America Acquisition Corp.

Accession: 0001213900-26-051018

Filed: 2026-05-01

Period: 2026-04-27

CIK: 0002028614

SIC: 6770 (BLANK CHECKS)

Item: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Item: Submission of Matters to a Vote of Security Holders

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — ea0288774-8k_drugs.htm (Primary)

EX-3.1 — FORM OF AMENDMENT TO SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, ADOPTED ON APRIL 27, 2026 (ea028877401ex3-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0288774-8k_drugs.htm · Sequence: 1

false

--12-31

0002028614

2026-04-27

0002028614

DMAA:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOneeighthOfOneOrdinaryShareMember

2026-04-27

0002028614

DMAA:OrdinarySharesParValue0.0001PerShareMember

2026-04-27

0002028614

DMAA:RightsEachEntitlingHolderToReceiveOneeighthOfOneOrdinaryShareMember

2026-04-27

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or Section 15(d) of the

Securities Exchange Act of 1934

April 27, 2026

Date of Report (Date of earliest event reported)

Drugs Made In America Acquisition Corp.

(Exact Name of Registrant as Specified in Charter)

Cayman Islands

001-42467

99-2394788

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(I.R.S. Employer

Identification Number)

420 Lexington Avenue, Suite 1402

New York, NY

10170

(Address of Principal Executive Offices)

(Zip Code)

646-726-7074

Registrant’s telephone number, including

area code:

Not Applicable

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

DMAAU

The Nasdaq Stock Market LLC

Ordinary shares, par value $0.0001 per share

DMAA

The Nasdaq Stock Market LLC

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

DMAAR

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities

Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03. Amendments to Articles of Incorporation

or Bylaws; Change in Fiscal Year.

Drugs Made in America

Acquisition Corp. (the “Company”) held an extraordinary general meeting of Shareholders (the “Extraordinary

General Meeting”) at 10:00 a.m. on April 27, 2026 for the purposes of considering and voting upon:

●

Extension Proposal: A proposal, by special resolution, to amend the Company’s Second Amended and Restated Memorandum and Articles of Association (the “Existing Charter”) by adopting an amendment to the Existing Charter in the form set forth in Annex A to the Proxy Statement (the “Extension Amendment”) which reflects the extension of the date by which the Company must consummate a business combination (the “Combination Period”) up to twelve (12) times from April 29, 2026 (the “Termination Date”) to April 29, 2027, each by an additional one (1) month (each an “Extension”) for a total of 12 months after the Termination Date, assuming a Business Combination has not occurred, so long as the Company’s sponsor deposits the lessor of $300,000 or $0.04 per non redeemed public share for each one-month extension period into the Trust Account;

●

Adjournment Proposal: A proposal, by ordinary resolution to adjourn the Extraordinary General Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the Extraordinary General Meeting, there are not sufficient votes to approve the Extension Proposal, or for such other reasons as the Chairman of the Extraordinary General Meeting, in his sole discretion, shall deem appropriate.

For more information

on these proposals, please refer to the Company’s proxy statement dated April 14, 2026 (the “Proxy Statement”).

The Extension Proposal was approved by the shareholders at the Extraordinary General Meeting.

The foregoing description

of the Extension Amendment is a summary only and is qualified in its entirety by reference to the full text of the Form of Amendment to

the Second Amended and Restated Memorandum and Articles of Association, which is attached hereto as Exhibit 3.1 and incorporated by reference

herein.

Item 5.07. Submission of Matters to a Vote

of Security Holders.

The disclosure set forth in Item 5.03 above is

incorporated into this Item 5.07 by reference.

As of April 7, 2026, the record date for the Extraordinary

General Meeting, there were 33,517,143 ordinary shares issued and outstanding, entitled to vote at the Extraordinary General Meeting.

At the Extraordinary General Meeting, there were 23,798,927 shares voted by proxy or in person, or approximately 70.58% of the shares

issued and outstanding and entitled to vote at the Extraordinary General Meeting; therefore a quorum was present.

The Extension Proposal was approved by special

resolution of the Company’s shareholders, and received the following votes:

FOR

AGAINST

ABSTAIN

18,906,281

4,892,646

The Adjournment Proposal was not presented to

the shareholders because, as disclosed in the Proxy Statement, there were sufficient votes to approve the Extension Proposal.

Item 8.01. Other Events.

In connection with the shareholders’

vote at the Extraordinary General Meeting, holders of 9,440,230 ordinary shares of the Company exercised their right to redeem such

shares (the “Redemption”) for a pro rata portion of the funds held in the Trust Account. As a result,

$99,336,016.67 (approximately $10.52 per share) will be removed from the Trust Account to pay such holders. Following the

aforementioned Redemption, the Company will have 24,276,913 ordinary shares outstanding including 13,559,770 sold in the initial public offering.

The Board of Directors of the Company has approved an initial one-month extension of the term to May 29, 2026.

Item 9.01 Financial Statements and Exhibits.

Exhibit

Number

Description

3.1

Form of Amendment to Second Amended and Restated Memorandum and Articles of Association, adopted on April 27, 2026

104

Cover Page Interactive Data File

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Dated: May 1, 2026

DRUGS MADE IN AMERICA ACQUISITION CORP.

By:

/s/ Roger Bendelac

Name:

Roger Bendelac

Title:

Chief Executive Officer

EX-3.1 — FORM OF AMENDMENT TO SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, ADOPTED ON APRIL 27, 2026

EX-3.1

Filename: ea028877401ex3-1.htm · Sequence: 2

Exhibit 3.1

AMENDMENT TO THE SECOND AMENDED AND RESTATED

MEMORANDUM AND ARTICLES

OF ASSOCIATION OF DRUGS MADE IN AMERICA ACQUISITION CORP.

SPECIAL RESOLUTION OF THE SHAREHOLDERS OF THE

COMPANY

RESOLVED,

AS A SPECIAL RESOLUTION, THAT the Second Amended and Restated Memorandum and Articles of Association of the Company be amended as

follows:

Article

48.7 shall be deleted in its entirety and replaced by the following:

48.7 In the

event that the Company does not consummate a Business Combination by April 29, 2027 by depositing $0.02 per non-redeemed Public Share

into the Trust Account each month until April 29, 2027, or such later time as the Members may approve in accordance with the Articles,

the Company shall:

Article 48.8

(a) shall be deleted in its entirety and replaced by the following:

48.8 In the event that any amendment

is made to the Articles:

(a) to modify

the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or redeem 100%

of the Public Shares if the Company does not consummate a Business Combination by April 29, 2027 by depositing the lesser of $300,000

or $0.04 per non-redeemed Public Share into the Trust Account each month until April 29, 2027; or

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Apr. 27, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 27, 2026

Current Fiscal Year End Date

--12-31

Entity File Number

001-42467

Entity Registrant Name

Drugs Made In America Acquisition Corp.

Entity Central Index Key

0002028614

Entity Tax Identification Number

99-2394788

Entity Incorporation, State or Country Code

Entity Address, Address Line One

420 Lexington Avenue

Entity Address, Address Line Two

Suite 1402

Entity Address, City or Town

New York

Entity Address, State or Province

Entity Address, Postal Zip Code

10170

City Area Code

646

Local Phone Number

726-7074

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

Title of 12(b) Security

Units, each consisting of one Ordinary share, $0.0001 par value and one right to receive one-eighth of one ordinary share

Trading Symbol

DMAAU

Security Exchange Name

NASDAQ

Ordinary shares, par value $0.0001 per share

Title of 12(b) Security

Ordinary shares, par value $0.0001 per share

Trading Symbol

DMAA

Security Exchange Name

NASDAQ

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

Title of 12(b) Security

Rights, each entitling the holder to receive one-eighth of one Ordinary Share

Trading Symbol

DMAAR

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name:

dei_CurrentFiscalYearEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:gMonthDayItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOneeighthOfOneOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_OrdinarySharesParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=DMAA_RightsEachEntitlingHolderToReceiveOneeighthOfOneOrdinaryShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: